Ausdal Financial Partners »

Oncolytics Biotech shares owned by Ausdal Financial Partners

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Ausdal Financial Partners from 13F filings

Historical chart of Ausdal Financial Partners investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Ausdal Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Ausdal Financial Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $28k 26k 1.06
2023-12-31 $41k 30k 1.35
2023-09-30 $44k 20k 2.18

More positions owned by Ausdal Financial Partners

Ishares Tr Short Treas Bd (SHV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Caterpillar (CAT)
Ishares Tr Msci Acwi Etf (ACWI)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Apple (AAPL)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Microsoft Corporation (MSFT)
Wisdomtree Tr Floatng Rat Trea (USFR)
Ishares Tr Rus 1000 Etf (IWB)

View all positions for Ausdal Financial Partners

Top funds holding Oncolytics Biotech

International Assets Investment Management
Millennium Management
Citadel Advisors
Commonwealth Equity Services
Royal Bank of Canada
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
Two Sigma Securities
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Banque Cantonale Vaudoise
Headinvest
Jpmorgan Chase & Co
Kingsview Wealth Management

View all funds holding Oncolytics Biotech